Jeffrey N; McKhann, Guy M; Sheth, Sameer A; Lesser, Jeraldine; Cheng, Simon K; Isaacson, Steven R; Lassman, Andrew B; Connolly, Eileen P; Wang, Tony J C.J Neurooncol; 127(1): 103-10, 2016 Mar.122.Factores pronosticos en el cancer de mama en estadio inicial. / [Prognostic factors of early breast cancer].Almagro, Elena; Gonzalez, Cynthia S; Espinosa, Enrique.Med Clin (Barc); 146(4): 167-71, 2016 Feb 19.123.Bone marrow micrometastases in early breast cancer-30-year outcome.Mansi, J; Morden, J; Bliss, J M; Neville, M; Coombes, R C.Br J Cancer; 114(3): 243-7, 2016 Feb 2.124.Prognostic value of circulating tumor cells in metastatic breast cancer: a systemic review and meta-analysis.Lv, Q; Gong, L; Zhang, T; Ye, J; Chai, L; Ni, C; Mao, Y.Clin Transl Oncol; 18(3): 322-30, 2016 Mar.125.The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.Ignatiadis, Michail; Azim, Hatem A; Desmedt, Christine; Veys, Isabelle; Larsimont, Denis; Salgado, Roberto; Lyng, Maria B;Viale, Giuseppe; Leyland-Jones, Brian; Giobbie-Hurder, Anita; Kammler, Rosita; Dell'Orto, Patrizia; Rothe, Francoise;Laios, Ioanna; Ditzel, Henrik J; Regan, Meredith M; Piccart, Martine; Michiels, Stefan; Sotiriou, Christos.JAMA Oncol; 2(2): 217-24, 2016 Feb.126.Circulating tumor cells in breast cancer.Bidard, Francois-Clement; Proudhon, Charlotte; Pierga, Jean-Yves.Mol Oncol; 10(3): 418-30, 2016 Mar.127.The Glasgow Prognostic Score Predicts Response to Chemotherapy in Patients with Metastatic Breast Cancer.Wang, Dexing; Duan, Li; Tu, Zhiquan; Yan, Fei; Zhang, Cuicui; Li, Xu; Cao, Yuzhu; Wen, Hongsheng.Chemotherapy; 61(4): 217-22, 2016.128.Ki67 expression in breast cancer. Correlation with prognostic markers and clinicopathological parameters in Saudi patients.Elkablawy, Mohamed A; Albasri, Abdulkader M; Mohammed, Rabab A; Hussainy, Akbar S; Nouh, Magdy M; Alhujaily, Ahmed S.Saudi Med J; 37(2): 137-41, 2016 Feb.129.HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression Analysis.Abdel-Fatah, Tarek M A; McArdle, Stephanie E B; Agarwal, Devika; Moseley, Paul M; Green, Andrew R; Ball, Graham R;Pockley, A Graham; Ellis, Ian O; Rees, Robert C; Chan, Stephen Y T.Clin Cancer Res; 22(4): 905-14, 2016 Feb 15.130.Low Concordance between Gene Expression Signatures in ER Positive HER2 Negative Breast Carcinoma Could Impair Their Clinical Application.Laas, Enora; Mallon, Peter; Duhoux, Francois P; Hamidouche, Amina; Rouzier, Roman; Reyal, Fabien.PLoS One; 11(2): e0148957, 2016.131.Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatment.Galimberti, V; Ribeiro Fontana, S K; Maisonneuve, P; Steccanella, F; Vento, A R; Intra, M; Naninato, P; Caldarella, P;Iorfida, M; Colleoni, M; Viale, G; Grana, C M; Rotmensz, N; Luini, A.Eur J Surg Oncol; 42(3): 361-8, 2016 Mar.132.Circulating tumor cells in breast cancer--current status and perspectives.Banys-Paluchowski, Malgorzata; Krawczyk, Natalia; Meier-Stiegen, Franziska; Fehm, Tanja.Crit Rev Oncol Hematol; 97: 22-9, 2016 Jan.133.Simultaneous Detection of Disseminated and Circulating Tumor Cells in Primary Breast Cancer Patients.Hartkopf, Andreas D; Wallwiener, Markus; Hahn, Markus; Fehm, Tanja N; Brucker, Sara Y; Taran, Florin-Andrei.Cancer Res Treat; 48(1): 115-24, 2016 Jan.134.Biologic subtype is a more important prognostic factor than nodal involvement in patients with stages I and II breast carcinoma.Kim, Hyosun; Cho, Jihyoung; Kwon, Sun Young; Kang, Sun Hee.Ann Surg Treat Res; 90(1): 1-9, 2016 Jan.135.Circulating tumor cells in breast cancer patients.Bystricky, B; Mego, M.Neoplasma; 63(1): 18-29, 2016.136.Circulating tumor cells in breast cancer beyond the